Your cart is currently empty!
Categories
- BPC-157
- CJC-1295 (with DAC)
- CJC-1295 No Dac
- Epithalon
- Follistatin
- General Peptide
- GHK-cu (Copper Peptide)
- GLP-1/GIP
- GnRH (Gonadotropin-Releasing Hormone)
- HCG (Human Chorionic Gonadotropin)
- Ipamorelin
- Kisspeptin
- Melanotan II (MT2)
- MK-677 (Ibutamoren)
- MOTS-c
- NAD+
- Oxytocin
- Peptide Storage
- Peptides
- PT-141 (Bremelanotide)
- Research Dosages
- Research Supplies
- Retatrutide
- Selank
- Semaglutide
- SNAP-8
- TB500 (Thymosin Beta-4)
- Tirzepatide
- Topical Peptides
Social Links
Retatrutide Shows Significant Weight Loss in Phase 2 Study
Retatrutide, an investigational triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, has shown considerable promise in promoting weight loss. Clinical trials have reported significant reductions in body weight for individuals receiving the drug. One Phase 2 study, conducted over 48 weeks, found that participants receiving the 12 mg dose experienced an average weight loss…
Power of GLP-1 for Drug, Alcohol Addiction, and Binge Eating
In addition to its use for weight loss and diabetes, there is a growing interest in the potential of GLP-1 receptor agonists for the treatment of various types of addiction, including opioid, cocaine, alcohol, binge eating, and other substance use disorders. While the research is still developing, several studies have suggested that GLP-1 receptor agonists…
Retatrutide Research Dosages
Below are potential future clinical trial dosages that might be explored for weight loss research based on studies cited by other research. *Administered subcutaneously 1x weekly Schedule Weekly Dose in Milligrams (mg) Weekly Dose Converted to Micrograms (mcg) Week 1 – 4 2 mg 2000 mcg Week 5 – 8 4 mg 4000 mcg Week…
What is Retatrutide
Retatrutide is a medication that is currently under investigation for its potential to treat obesity and type 2 diabetes. It’s a novel drug that works by targeting and activating specific receptors involved in appetite regulation and metabolic processes. Retatrutide belongs to a class of drugs known as dual or triple agonists, which means it can…